Tech Center 1600 • Art Units: 1600 1614 1621 1629 1691
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18281674 | METHODS AND MATERIALS FOR TREATING CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18292329 | SLC26A3 INHIBITORS AND USE THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18769264 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Non-Final OA | Auspex Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy